Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
about
Lung transplantation: a treatment option in end-stage lung disease.Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study.International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.Post-transplant lymphoproliferative disorder presenting on post-transplant Day 35 as a pulmonary parenchymal infiltrate-a case report
P2860
Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Posttransplantation lymphoprol ...... single institution experience.
@en
Posttransplantation lymphoprol ...... single institution experience.
@nl
type
label
Posttransplantation lymphoprol ...... single institution experience.
@en
Posttransplantation lymphoprol ...... single institution experience.
@nl
prefLabel
Posttransplantation lymphoprol ...... single institution experience.
@en
Posttransplantation lymphoprol ...... single institution experience.
@nl
P2093
P1433
P1476
Posttransplantation lymphoprol ...... single institution experience.
@en
P2093
Eli Muchtar
Ilana Bakal
Liat Vidal
Mordechai R Kramer
Ofer Shpilberg
Ronit Gurion
Yivgenia Rosenblat
P304
P356
10.1097/TP.0B013E31829B0718
P577
2013-10-01T00:00:00Z